Variations in US county‐level trends in buprenorphine use, 2018–2022
From 2018 to 2022, buprenorphine use as treatment for opioid use disorder increased in some United States counties, notably counties with more residents living in rural areas and counties with more prescriptions written by nurse practitioners. However, declining use in other US counties suggest challenges persist in increasing access to medication for treament of opioid use disorder, hindering progress in addressing the opioid crisis.
Authors
- Grace Chai (ORCID: https://orcid.org/0000-0001-7893-723X)
- Sonal Goyal (ORCID: https://orcid.org/0000-0002-7381-4473)
- Mónica Muñoz (ORCID: https://orcid.org/0000-0001-9754-1986)
- Gerald J. Dal Pan (ORCID: https://orcid.org/0000-0003-4874-5864)
- Jing Xu (ORCID: https://orcid.org/0000-0003-3315-4420)
- Jaejoon Song (ORCID: https://orcid.org/0000-0003-0671-2191)
- Taylor W. Lefler
- Lisa T. Weissburg (ORCID: https://orcid.org/0009-0007-4579-5141)
Institutions
- United States Food and Drug Administration (US)
- Center for Drug Evaluation and Research (US)
Publication Details
- Journal
- Addiction
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1111/add.70264
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00